- Home
- PRVA vs NVST Comparison
PRVA vs NVST Comparison
Compare PRVA & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRVA
- NVST
- Stock Information
- Founded
- PRVA 2007
- NVST 2018
- Country
- PRVA United States
- NVST United States
- Employees
- PRVA N/A
- NVST N/A
- Industry
- PRVA Retail: Computer Software & Peripheral Equipment
- NVST Medical/Dental Instruments
- Sector
- PRVA Technology
- NVST Health Care
- Exchange
- PRVA Nasdaq
- NVST Nasdaq
- Market Cap
- PRVA 2.7B
- NVST 3.1B
- IPO Year
- PRVA 2021
- NVST 2019
- Fundamental
- Price
- PRVA $20.68
- NVST $20.21
- Analyst Decision
- PRVA Strong Buy
- NVST Buy
- Analyst Count
- PRVA 14
- NVST 12
- Target Price
- PRVA $28.50
- NVST $20.55
- AVG Volume (30 Days)
- PRVA 1.1M
- NVST 2.0M
- Earning Date
- PRVA 08-07-2025
- NVST 07-31-2025
- Dividend Yield
- PRVA N/A
- NVST N/A
- EPS Growth
- PRVA N/A
- NVST N/A
- EPS
- PRVA 0.12
- NVST N/A
- Revenue
- PRVA $1,801,244,000.00
- NVST $2,503,900,000.00
- Revenue This Year
- PRVA $90.63
- NVST $3.44
- Revenue Next Year
- PRVA $10.51
- NVST $3.23
- P/E Ratio
- PRVA $175.90
- NVST N/A
- Revenue Growth
- PRVA 6.79
- NVST N/A
- 52 Week Low
- PRVA $16.47
- NVST $14.22
- 52 Week High
- PRVA $26.09
- NVST $23.00
- Technical
- Relative Strength Index (RSI)
- PRVA 33.55
- NVST 59.82
- Support Level
- PRVA $21.76
- NVST $19.62
- Resistance Level
- PRVA $23.15
- NVST $21.08
- Average True Range (ATR)
- PRVA 0.66
- NVST 0.60
- MACD
- PRVA -0.10
- NVST 0.04
- Stochastic Oscillator
- PRVA 7.30
- NVST 68.30
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.